BRCA1 and BRCA2 play crucial roles in DNA double-strand break repair by homologous recombination, and prevalence of BRCA1/2 mutation in patients with newly diagnosed high-grade serous ovarian cancer is 20-25% (2011, [109–112]). Here, BRCA1 is linked to ovarian serous adenocarcinoma.